Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors

Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors

<i>Background and Objective:</i> We aim to determine the efficacy and the factors associated with the effectiveness of first-line CDK4/6i (ribociclib or palbociclib) treatment in HR-positive, HER2-negative MBC patients. <i>Materials and Methods:</i> This is a retrospective, c...

Full description

Saved in:
Bibliographic Details
Main Authors: Zehra Sucuoğlu İşleyen, Harun Muğlu, Zeynep Alaca Topçu, Mehmet Beşiroğlu, Ayşe İrem Yasin, Atakan Topçu, Melih Şimşek, Mesut Şeker, Hacı Mehmet Türk
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Medicina
Subjects:
metastatic breast cancer
CDK 4/6 inhibitors
ribociclib
palbociclib
Online Access:https://www.mdpi.com/1648-9144/61/7/1279
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items